CD40-mediated immune cell activation enhances response to anti-PD-1 in murine intrahepatic cholangiocarcinoma
Laurence P. Diggs(National Institutes of Health), Tim F. Greten(National Cancer Institute), Gregory J. Gores(Mayo Clinic in Arizona), Sabina Desar(National Institutes of Health), Bernd Heinrich(National Institutes of Health), Varun Subramanyam(National Institutes of Health), David E. Kleiner(National Institutes of Health), Linda L. Cui(National Institutes of Health), Qianfei Zhang(National Institutes of Health), Simon Wabitsch(National Institutes of Health), Thomas Longerich(Heidelberg University), Sven H. Loosen(Düsseldorf University Hospital), John C. McVey(National Institutes of Health), Chunwei W. Lai(National Institutes of Health), Benjamin Ruf(Research Institute for Work, Technology and Culture), Chi Ma(National Institutes of Health), Ulf P. Neumann(RWTH Aachen University), Xin Wei Wang(Ministry of Education of the People's Republic of China), Tom Luedde(Düsseldorf University Hospital), S. Heinrich(Medizinische Hochschule Hannover), Umberto Rosato(National Institutes of Health)
Cited by 148
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
|New England Journal of Medicine|2010|3.3k
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2016|2.7k
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k